Hindustan Agrigenetics
add_icon

Hindustan Agrigenetics

56.90
+2.90
(5.37%)
Market Cap
₹- Cr
PE Ratio
-
Volume
6,981.00
Day High - Low
₹56.99 - ₹55.20
52W High-Low
₹103.00 - ₹48.81
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
- Cr
EPS
-
PB Ratio
-
Book Value
28.29
EBITDA
-
Dividend Yield
- %
Industry
FMCG
ROE Growth %
-
Debt to Equity
-
Forecast For
Actual

Company News

View All News
Caret
positive
Hindustan Agrigenetics Limited's Board approved unaudited financial results for the quarter ended September 30, 2025, showing a profit after tax of Rs 16.85 lacs compared to a loss of Rs 40.19 lacs in the previous quarter. The company's total revenue increased to Rs 32.13 lacs from Rs 8.09 lacs, with cash and cash equivalents rising to Rs 5,38,13,854 from Rs 5,14,05,088.
neutral
Hindustan Agrigenetics Limited underwent significant leadership changes following a successful open offer. The board appointed Mrs. Vidya Jonnalagadda as a woman Independent Director. Five board members resigned including Mrs. Chandani Kapur, Mr. Sunny Srivastava, Mr. Naren Parsai, Mr. Pranav Kapur, and Ms. Mannu Kohli, with their resignations accepted by the board. Mr. Pritam Kapur also tendered his resignation but was requested to continue as Managing Director until December 15, 2025. Mr. Rajendra Naniwadekar will take over as Managing Director from December 15, 2025. The company formed three statutory committees: an Audit Committee chaired by P.K. Rambabu, a Nomination and Remuneration Committee chaired by Ravi Shankar Kolathur, and a Stakeholders Relationship Committee chaired by Shashank Vaidya.
positive
Hindustan Agrigenetics Limited appointed Vidya Sobhianaditya Jonnalagadda as a Non-Executive Independent Director during a Board meeting held on October 18, 2025. The appointment is subject to shareholder approval. Jonnalagadda brings over 40 years of experience as a biology researcher and teacher, holding a PhD from University of Pennsylvania. She has worked at various prestigious institutions including Indian Institute of Science, Fox Chase Cancer Center, and Massachusetts Institute of Technology. She transitioned from research to teaching about 20 years ago, specializing in genetics, molecular biology, virology, and immunology at undergraduate and post-graduate levels. The appointee has no relationships with existing directors and is neither a willful defaulter nor barred by any regulator.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
11.85
-
#1 -
-
-
-
-
31.88
144.70
-
#1 -
-
-
-
-
52.16
22.30
-
#1 -
-
-
-
-
48.24
104.90
-
#1 -
-
-
-
-
37.80
129.10
-
#1 -
-
-
-
-
48.89
141.04
-
#1 -
-
-
-
-
45.55
42.00
-
#1 -
-
-
-
-
29.87
82.70
-
#1 -
-
-
-
-
36.18
31.00
-
#1 -
-
-
-
-
23.44
4.28
-
#1 -
-
-
-
-
20.19
Growth Rate
Revenue Growth
-
Net Income Growth
-
Cash Flow Change
-
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
Revenue
0
1
0
0
0
0
0
0
11
1
0
1
Expenses
0
0
0
0
0
1
0
0
1
0
1
1
EBITDA
0
1
0
0
-0
-0
-0
-0
10
1
-1
0
Operating Profit %
-112 %
-100 %
-157 %
-315 %
-399 %
-262 %
-291 %
-276 %
-1,055 %
-442 %
-1 %
-244 %
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
0
1
0
0
-0
-0
-0
-0
10
1
-0
0
Tax
0
0
0
1
0
-1
0
0
0
0
0
0
Net Profit
0
1
0
-1
-0
0
-0
-0
10
1
-0
0
EPS in ₹
0.20
1.51
0.25
-1.35
-0.26
0.74
-0.33
-0.22
22.40
1.07
-0.69
0.20

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
3
3
3
2
2
3
3
8
12
13
12
Fixed Assets
0
0
0
0
0
0
0
0
0
0
0
Current Assets
2
2
2
2
2
1
2
7
11
12
11
Capital Work in Progress
0
0
0
0
0
0
0
0
0
0
0
Investments
2
2
2
2
1
0
1
2
1
2
0
Other Assets
1
1
1
0
0
2
1
6
12
11
0
Total Liabilities
3
3
3
2
2
3
3
8
12
13
12
Current Liabilities
1
0
0
0
0
0
1
6
1
0
0
Non Current Liabilities
0
0
0
0
0
0
0
0
0
0
0
Total Equity
2
3
3
2
2
2
2
2
12
12
12
Reserve & Surplus
-2
-2
-2
-2
-3
-2
-2
-2
8
8
8
Share Capital
4
4
4
4
4
4
4
4
4
4
4

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
0
0
0
0
0
0
-0
5
5
-1
-4
Investing Activities
0
0
0
0
0
1
-1
-0
12
-1
-4
Operating Activities
0
0
-0
-0
-0
-1
1
5
-7
0
0
Financing Activities
0
0
0
0
0
0
0
0
0
0
0

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Promoter
29.42 %
29.42 %
29.42 %
29.42 %
29.42 %
29.42 %
29.42 %
29.42 %
29.42 %
29.42 %
29.42 %
29.42 %
29.42 %
28.41 %
9.61 %
9.47 %
8.20 %
8.17 %
25.35 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.13 %
0.13 %
0.13 %
0.43 %
0.43 %
0.43 %
0.43 %
DIIs
1.08 %
1.08 %
1.08 %
1.08 %
1.08 %
1.08 %
1.38 %
1.38 %
1.38 %
1.08 %
1.38 %
1.08 %
1.38 %
1.38 %
1.38 %
1.08 %
1.08 %
1.08 %
1.08 %
Government
8.44 %
8.44 %
8.44 %
8.44 %
8.44 %
8.44 %
8.44 %
8.44 %
8.44 %
8.44 %
8.44 %
8.44 %
8.44 %
8.44 %
8.44 %
8.44 %
8.44 %
8.44 %
8.44 %
Public / Retail
42.08 %
42.08 %
42.08 %
42.08 %
42.08 %
42.08 %
42.08 %
42.08 %
42.08 %
42.08 %
42.08 %
42.08 %
35.11 %
36.07 %
54.76 %
72.47 %
74.68 %
73.56 %
53.21 %
Others
18.98 %
18.98 %
18.98 %
18.98 %
18.98 %
18.98 %
18.68 %
18.68 %
18.68 %
18.98 %
18.68 %
18.98 %
25.53 %
25.58 %
25.69 %
8.11 %
7.17 %
8.32 %
11.50 %
No of Share Holders
0
5,733
5,733
5,733
5,733
5,733
5,732
5,732
5,731
5,731
5,750
5,750
6,478
6,967
7,361
7,520
7,467
7,454
7,669

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
24 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
24 Sept 2024 77.94 58.22
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 53.00 49.00
14 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Feb 2025 77.90 69.99
30 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 May 2025 72.35 75.24
14 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Aug 2025 68.50 67.26
27 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
27 Sept 2025 66.78 63.00
14 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2025 56.72 57.29

Announcements

Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 17, 2025
Disclosure Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Nov 14, 2025
Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025Nov 14, 2025
Board Meeting Outcome for Please Find Attached Herewith The Un-Audited Financial Result For The Quarter And Half Year Ended 30Th September 2025.Nov 14, 2025
Board Meeting Intimation for Holding The Board Meeting On 14.11.2025 For Consider And Approve The Un-Audited Financial Results Of The Company For The Quarter Ended As On 30Th September 2025Nov 10, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 28, 2025
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 24, 2025
Outcome Of The Board MeetingOct 18, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementOct 18, 2025
Announcement under Regulation 30 (LODR)-Resignation of DirectorOct 18, 2025
Intimation Regarding The Appointment Of An Additional Director To The Board Of Directors Of The Company Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Oct 18, 2025
Notice For The Meeting Of The Board Of Directors Dated 18Th October 2025. The Agenda Will Be 1. Appointment Of A Woman Director 2. Reconstitution Of Statutory Committees. Oct 16, 2025
Intimation Of Duplicate Share CertificatesOct 08, 2025
Post Offer AdvertisementOct 08, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementSep 30, 2025
Re-Classification Of Promoter GroupSep 30, 2025
Board Meeting Outcome for Intimation Under Regulation 30 And 31A(10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Open Offer To The Shareholders Of Hindustan Agrigenetics Limited (Open Offer) By Rajendra Naniwadekar (AcquirSep 30, 2025
Intimation Of The Receipt Of Request For The Re-Classification From The Public To The Promoter Category In Accordance With Regulation 31A Of The SEBI (LODR) Regulation 2015Sep 30, 2025
Proceedings Of The AGMSep 27, 2025
PROCEEDINGS OF THE ANNUAL GENERAL MEETINGSep 27, 2025
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sSep 27, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 27, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 27, 2025
Closure of Trading WindowSep 26, 2025
Closure of Trading WindowSep 26, 2025
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateSep 19, 2025
Intimation Of Book Closure & Cut-Off Date For Annual General Meeting.Sep 09, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 09, 2025
Shareholders Providing Web-Link For Accessing The Annual Report For The Financial Year 2024-25.Sep 09, 2025
Disclosure under Regulation 30A of LODRSep 06, 2025
Updates on Open OfferSep 01, 2025
The Company Here By Submit The Notice Of The 35Th Annual General Meeting Of The Company To Be Held On 27Th September 2025.Sep 01, 2025
Reg. 34 (1) Annual Report.Sep 01, 2025
Updates on Open OfferAug 29, 2025
Letter of OfferAug 29, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 29, 2025
Outcome Of Meeting Of Committee Of Independent Directors For Open Offer Of CompanyAug 28, 2025
Board Meeting Intimation for Calling Of Annual General Meeting Of The Company.Aug 26, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 22, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 22, 2025
Board Meeting Outcome for Approval Of Un-Audited Financial Results For The Quarter Ended 30.06.2025Aug 14, 2025
Un-Audited Financial Results For The Quarter Ended 30.06.2025.Aug 14, 2025
Board Meeting Intimation for To Consider And Approve The Un-Audited Financial Results Of The Company For The Quarter Ended As On 30Th June 2025Aug 08, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 09, 2025
Closure of Trading WindowJun 26, 2025
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateJun 26, 2025
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateJun 26, 2025
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateJun 24, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 06, 2025
APPOINTMENT OF SECRETARIAL AUDITORSMay 30, 2025

Technical Indicators